www.fdanews.com/articles/131180-gsk-rsquo-s-target-200-rare-diseases

GSK’s Target: 200 Rare Diseases

October 18, 2010

Pharmaceutical giant GlaxoSmithKline said Monday that its rare disease unit formed earlier this year plans to target about 200 diseases.
NewsObserver